Novozymes A/S

OTC: NVZMF · Real-Time Price · USD
67.38
0.00 (0.00%)
At close: Aug 12, 2025, 3:54 PM
67.38
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Novozymes A/S Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3.83B 17.9B 17.55B 14.95B
Cost of Revenue
2.02B 8.18B 7.96B 6.33B
Gross Profit
1.81B 9.72B 9.58B 8.62B
Operating Income
659M 3.98B 4.63B 4.01B
Interest Income
n/a 16.74M 18M 18M
Pretax Income
417.1M 3.91B 4.56B 3.92B
Net Income
305.8M 3.02B 3.68B 3.15B
Selling & General & Admin
765.5M 3.32B 3.22B 2.79B
Research & Development
413.2M 2.02B 2B 2.01B
Other Expenses
-28.2M 405M -37.04M -66M
Operating Expenses
1.15B 5.75B 5.03B 4.74B
Interest Expense
n/a 23.24M 102M 102M
Selling & Marketing Expenses
550.9M 2.37B 2.27B 1.94B
Cost & Expenses
3.17B 13.92B 13.13B 11.07B
Income Tax Expense
111.3M 870M 870M 779M
Shares Outstanding (Basic)
456.42M 277.94M 278.7M 277.92M
Shares Outstanding (Diluted)
456.42M 277.87M 278.73M 280.23M
EPS (Basic)
0.67 10.88 13.29 11.32
EPS (Diluted)
0.67 10.88 13.19 11.23
EBITDA
659M 5.47B 5.72B 5.4B
EBIT
659M 4.08B 4.66B 4.03B
Depreciation & Amortization
n/a 1.39B 1.46B 1.37B